Gene Logic to Present at the 2005 Rodman and Renshaw Techvest 7th Annual Healthcare Conference

Gene Logic Inc. (NASDAQ:GLGC) announced today that its
Chief Executive Officer and President, Mark D. Gessler, will present
at the 2005 Rodman and Renshaw Techvest 7th Annual Healthcare
Conference. The presentation will be held at the New York Palace Hotel
on Wednesday, November 9, 2005, and Mr. Gessler's presentation will
begin at 11:55 a.m. (ET).
   The presentation will be webcast live and can be accessed at
www.genelogic.com under Investors/Company Overview. The webcast will
be archived for 30 days following the presentation and will be
available under Investors/Webcasts.

   Gene Logic Overview

   Gene Logic is leading the transformation of pharmaceutical
research and development with its extensive gene expression databases,
pioneering efforts in toxicogenomics, sophisticated bioinformatics
expertise, specialty non-clinical testing capabilities and cutting
edge technology program for drug repositioning. Gene Logic
technologies and services are used by many of the world's top
pharmaceutical and biotechnology companies. Over 150 organizations and
government agencies have benefited from Gene Logic's diverse portfolio
of drug development services, enabling them to make more informed,
more reliable and more predictive decisions at each point in the
highly complex and costly drug development process. Founded in 1994,
Gene Logic is headquartered in Gaithersburg, Md., with additional
research and development facilities in Cambridge, Mass. and Berkeley,
Calif. The Company maintains customer support operations in Europe and
Asia and currently has about 450 employees worldwide. For more
information, visit www.genelogic.com or call toll-free -
1/800/GENELOGIC.